Ovarian Cancer | Data + Perspectives: Clinical Investigators Discuss the Current and Future Management of Ovarian Cancer

Featuring perspectives from Drs Mansoor Mirza, Kathleen Moore and David O’Malley, moderated by Dr Robert Coleman, including the following topics: Introduction (0:00) Optimal Biomarker Evaluation and Management of Treatment-Naïve Advanced Ovarian Cancer (OC) — Kathleen N Moore, MD, MS (5:05) Treatment of Recurrent OC; Ongoing Research Efforts with PARP Inhibitors for Newly Diagnosed and Relapsed Disease — David M O’Malley, MD (28:50) Recognition and Management of Side Effects Associated with PARP Inhibitor Therapy for OC — Mansoor Raza Mirza, MD (49:59) Novel Investigational Agents and Strategies in OC — Robert L Coleman, MD (1:09:14) CME information and select publications